Skip to content
value.today

Johnson & Johnson vs Pharmadax

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $98 M for Pharmadax, 6658 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 7, 2022 for Pharmadax). Pharmadax's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

043851281702020202120222023202420252026Johnson & Johnson 170Pharmadax 118

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B20182019202020212022202320242025Johnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureJohnson & Johnson
JNJ · #23 in the world
Pharmadax
4191.TWO
Profile
Country🇺🇸 USA🇹🇼 Taiwan
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded1886—
Size
Market cap$652.5 B$98 M*
Revenue$94.2 B—
Net income$26.8 B—
Employees138,200—
Valuation
P/E ratio40.5×—
Price to sales6.6×—
Price to book8.0×—
Free cash flow yield3.0%—
Altman Z-score zone——
Data as ofMarket cap Oct 2026Market cap Jan 2022

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Johnson & Johnson or Pharmadax?

Johnson & Johnson is the larger company by market value: $652.5 B against $98 M for Pharmadax, 6658 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 7, 2022 for Pharmadax). Pharmadax's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.

Sources#

Every figure on this page comes from these, with the date shown next to it.